Your browser doesn't support javascript.
loading
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
Ramanathan, Ramesh K; Ramalingam, Sakkaraiappan; Egorin, Merrill J; Belani, Chandra P; Potter, Douglas M; Fakih, Marwan; Jung, Laura L; Strychor, Sandra; Jacobs, Samuel A; Friedland, David M; Shin, Dong M; Chatta, Gurkamal S; Tutchko, Susan; Zamboni, William C.
Afiliação
  • Ramanathan RK; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. ramanathanrk@upmc.edu.
  • Ramalingam S; Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA. ramanathanrk@upmc.edu.
  • Egorin MJ; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Belani CP; Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.
  • Potter DM; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Fakih M; Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.
  • Jung LL; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Strychor S; Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.
  • Jacobs SA; Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.
  • Friedland DM; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
  • Shin DM; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Chatta GS; Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.
  • Tutchko S; Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.
  • Zamboni WC; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Cancer Chemother Pharmacol ; 55(4): 354-360, 2005 Apr.
Article em En | MEDLINE | ID: mdl-15723261
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astenia / Protocolos de Quimioterapia Combinada Antineoplásica / Taxoides / Desoxicitidina / Neoplasias Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astenia / Protocolos de Quimioterapia Combinada Antineoplásica / Taxoides / Desoxicitidina / Neoplasias Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article